Back

Value of baseline clinical and CMR characteristics for the prediction of cancer therapeutics-related cardiac dysfunction: results from the Cardiotoxicity Prevention Research Initiative (CAPRI)

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Cardio-Oncology ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Dina Labib

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)

155 More presentations in this session

Presentation thumbnail
Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study
Miss M. Koopman (Groningen, NL)
Abstract Slides
Presentation thumbnail
Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals
Doctor C. Liu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Characteristics and health status of patients with and without confirmed HFpEF
Professor C. Deaton (Cambridge, GB)
Abstract Slides
Presentation thumbnail
Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy
Mr A. Nikhanj (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.
Doctor F. Fioravanti (Milan, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources